Grifols (GIKLY) Shareholder's Equity Growth (1y) (2011 - 2025)

Grifols (GIKLY) Shareholder's Equity Growth (1y) (2011 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.40%
Dec 31, 2024 -22.23%
Dec 31, 2023 -0.68%
Dec 31, 2022 3.73%
Dec 31, 2021 1,539.99%
Dec 31, 2020 -107.19%
Dec 31, 2019 41.35%
Dec 31, 2018 25.29%
Jun 30, 2018 20.32%
Dec 31, 2017 6.30%
Jun 30, 2017 2.19%
Dec 31, 2016 11.23%
Sep 30, 2016 10.70%
Dec 31, 2015 8.73%
Dec 31, 2014 36.86%
Dec 31, 2013 5.39%
Sep 30, 2013 14.89%
Jun 30, 2013 -0.93%
Mar 31, 2013 17.04%
Dec 31, 2012 2.98%